Trial intelligence / Profile preview

Mitiglinide and Metformin Combination in Type 2 Diabetes

NCT01037842Phase 3Completed

Sponsor
Seoul National University Hospital
Start
Aug 2006
Primary completion
Mar 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of mitiglinide in type 2 diabetes mellitus (T2DM), sponsored by Seoul National University Hospital. Started Aug 2006; status: completed.

02

Drugs

mitiglinide
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT01037842.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01037842.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call